Newsletter | September 3, 2025

09.03.25 -- STREAM Edition: Why AbbVie Moved Risk Assessment To The Draft Protocol Stage

SPONSOR

 

 

Join us on September 24, 2025, for a free virtual expo tailored to clinical teams evaluating IRT/RTSM platforms. Get live 15-minute demos, real-time Q&A, and side-by-side comparisons from top vendors. Ideal for Clinical Ops, Trial Supply, Data Management, and Procurement professionals, this event helps accelerate vendor selection and streamline study planning.

How Optimized Trials Enhance Patient Enrollment, Retention, And More

Webinar | Elligo Health Research®

Watch as experts from Elligo discuss the benefits, challenges, and solutions associated with optimized trials. Discover how leveraging these strategies can solve key issues in clinical research.

Innovations In IRT

Video | IQVIA Technologies

Review the latest innovative techniques employed by IQVIA IRT, including innovations in the design, delivery, conduct and monitoring of clinical trials.

Why AbbVie Moved Risk Assessment To The Draft Protocol Stage

Video | Clinical Leader

Ann Hale, Head of Study Risk Management and Central Monitoring at AbbVie, discusses the company's shift toward earlier risk assessments in the protocol development process using cross-functional teams. She emphasizes the importance of data criticality assessments and asking the fundamental question "What is truly critical?" to identify genuine showstoppers versus nice-to-have data points.

Navigating The Regulatory Complexities Of Targeted Medicines In Oncology

Webinar | Cencora PharmaLex

Explore the strategic considerations for successfully navigating the regulatory complexities of targeted medicines. Learn about the challenges in translational medicine and key clinical development considerations.

The Team For Your Package Design Needs

Video | PCI Pharma Services

Our dedicated team of in-house design specialists deliver insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions.

Beyond The Data Deluge: Immune Profiling In Early Immuno-Oncology Trials

Webinar | Precision for Medicine

This presentation explores how to design effective immune monitoring for early-phase immuno-oncology trials, focusing on strategic platform selection, cost, and operational feasibility.

SPONSOR

 

 

Revolutionize your approach to clinical trials at DPHARM: Disruptive Innovations to Modernize Clinical Research, taking place September 16–17, 2025, in Philadelphia. This conference showcases cutting-edge strategies and technologies designed to reduce patient and site burden, streamline operations, improve data quality, and accelerate access to therapies.